Practical strategies for creating diversity, equity, inclusion, and access in cancer clinical research: DRIVE

por Birhiray, Maya N., Birhiray, Ruemu E.
Publicado 2022

Atypical identification of Lynch syndrome by immunohistochemistry and microsatellite instability analysis on jejunal adenocarcinoma

por McIlvried, Dawn E, Birhiray, Ruemu E, Lu, Jim Z
Publicado 2011

Resection of a mature cystic teratoma of the liver harboring a carcinoid tumor

por Krainev, Alexei A, Mathavan, Viney K, Klink, Daniel, Fuentes, Rocio C, Birhiray, Ruemu
Publicado 2018

PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF...

por Girnius, Saulius K., Richter, Joshua, Lyons, Roger M., Bogard, Kimberly, Manda, Sudhir, Birhiray, Ruemu E., Yimer, Habte A., Tran, Kim, Kambhampati, Suman, Arora, Jyoti, Noga, Stephen, Rifkin, Robert
Publicado 2023

In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management

por Rifkin, Robert M., Girnius, Saulius K., Noga, Stephen J., Birhiray, Ruemu E., Kambhampati, Suman, Manda, Sudhir, Lyons, Roger M., Yimer, Habte A., Cherepanov, Dasha, Lloyd, Eric, Whidden, Presley, Richter, Joshua
Publicado 2023

Feasibility of Long-term Proteasome Inhibition in Multiple Myeloma by in-class Transition From Bortezomib to Ixazomib

por Manda, Sudhir, Yimer, Habte A., Noga, Stephen J., Girnius, Saulius, Yasenchak, Christopher A., Charu, Veena, Lyons, Roger, Aiello, Jack, Bogard, Kimberly, Ferrari, Renda H., Cherepanov, Dasha, Demers, Brittany, Lu, Vickie, Whidden, Presley, Kambhampati, Suman, Birhiray, Ruemu E., Jhangiani, Haresh S., Boccia, Ralph, Rifkin, Robert M.
Publicado 2020